Connection

Marc Chimowitz to Humans

This is a "connection" page, showing publications Marc Chimowitz has written about Humans.
Connection Strength

1.014
  1. Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2022 04; 21(4):355-368.
    View in: PubMed
    Score: 0.032
  2. Silent Myocardial Infarction and Stroke Risk: We Should Be Listening. Neurology. 2021 08 03; 97(5):207-208.
    View in: PubMed
    Score: 0.030
  3. Dual Antiplatelet Therapy Beyond 90 days in Symptomatic Intracranial Stenosis in the SAMMPRIS Trial. J Stroke Cerebrovasc Dis. 2020 Dec; 29(12):105254.
    View in: PubMed
    Score: 0.029
  4. Relationship Between Vascular Risk Factors and Location of Intracranial Atherosclerosis in the SAMMPRIS Trial. J Stroke Cerebrovasc Dis. 2020 May; 29(5):104713.
    View in: PubMed
    Score: 0.028
  5. Stroke Caused by Atherosclerosis of the Major Intracranial Arteries. Circ Res. 2017 Feb 03; 120(3):502-513.
    View in: PubMed
    Score: 0.022
  6. Relationship between risk factor control and vascular events in the SAMMPRIS trial. Neurology. 2017 Jan 24; 88(4):379-385.
    View in: PubMed
    Score: 0.022
  7. Angioplasty and Stenting. Front Neurol Neurosci. 2016; 40:152-163.
    View in: PubMed
    Score: 0.022
  8. Enrollment volume effect on risk factor control and outcomes in the SAMMPRIS trial. Neurology. 2015 Dec 15; 85(24):2090-7.
    View in: PubMed
    Score: 0.021
  9. Yet again no benefit of stenting over medical therapy. Lancet Neurol. 2015 Jun; 14(6):565-6.
    View in: PubMed
    Score: 0.020
  10. Endovascular therapy for atherosclerotic intracranial arterial stenosis: back to the drawing board. JAMA. 2015 Mar 24-31; 313(12):1219-20.
    View in: PubMed
    Score: 0.020
  11. Infarct patterns, collaterals and likely causative mechanisms of stroke in symptomatic intracranial atherosclerosis. Cerebrovasc Dis. 2014; 37(6):417-22.
    View in: PubMed
    Score: 0.019
  12. Is calcification of intracranial arteries important and how? JAMA Neurol. 2014 Apr; 71(4):401-2.
    View in: PubMed
    Score: 0.018
  13. Game changer for endovascular treatment of acute ischemic stroke? J Neurointerv Surg. 2014 May; 6(4):252-3.
    View in: PubMed
    Score: 0.018
  14. Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists. Cerebrovasc Dis. 2014; 37(3):203-11.
    View in: PubMed
    Score: 0.018
  15. In reply: Is there a contribution of anesthesia to the outcome of the SAMMPRIS trial? Neurosurgery. 2014 Feb; 74(2):E235-6.
    View in: PubMed
    Score: 0.018
  16. The challenge of stroke prevention with intracranial arterial stenosis. Curr Cardiol Rep. 2013 Dec; 15(12):422.
    View in: PubMed
    Score: 0.018
  17. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2013 Nov; 12(11):1106-14.
    View in: PubMed
    Score: 0.018
  18. The Feinberg Award Lecture 2013: treatment of intracranial atherosclerosis: learning from the past and planning for the future. Stroke. 2013 Sep; 44(9):2664-9.
    View in: PubMed
    Score: 0.017
  19. Intracranial stenting: SAMMPRIS. Stroke. 2013 Jun; 44(6 Suppl 1):S41-4.
    View in: PubMed
    Score: 0.017
  20. Endovascular treatment for acute ischemic stroke--still unproven. N Engl J Med. 2013 Mar 07; 368(10):952-5.
    View in: PubMed
    Score: 0.017
  21. Response to critique of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial by Abou-Chebl and Steinmetz. Stroke. 2012 Oct; 43(10):2806-9.
    View in: PubMed
    Score: 0.017
  22. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011 Sep 15; 365(11):993-1003.
    View in: PubMed
    Score: 0.015
  23. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis. 2011 Jul-Aug; 20(4):357-68.
    View in: PubMed
    Score: 0.015
  24. E-pearl: brachial artery embolus mimicking acute stroke. Neurology. 2011 May 03; 76(18):e86-7.
    View in: PubMed
    Score: 0.015
  25. Risk of cerebral angiography in patients with symptomatic intracranial atherosclerotic stenosis. Cerebrovasc Dis. 2011; 31(6):588-91.
    View in: PubMed
    Score: 0.015
  26. Intraplaque hemorrhage in symptomatic intracranial atherosclerotic disease. J Neuroimaging. 2011 Apr; 21(2):e159-61.
    View in: PubMed
    Score: 0.015
  27. 10 questions about intracranial atherosclerotic stenosis. Neurologist. 2010 Nov; 16(6):400-5.
    View in: PubMed
    Score: 0.015
  28. Current status of the management of symptomatic intracranial atherosclerotic disease: the rationale for a randomized trial of medical therapy and intracranial stenting. J Neurointerv Surg. 2009 Jul; 1(1):35-9.
    View in: PubMed
    Score: 0.013
  29. Treatment of atherosclerotic intracranial arterial stenosis. Stroke. 2009 Jun; 40(6):2257-61.
    View in: PubMed
    Score: 0.013
  30. Racial differences in vascular risk factors and outcomes of patients with intracranial atherosclerotic arterial stenosis. Stroke. 2009 Mar; 40(3):719-25.
    View in: PubMed
    Score: 0.013
  31. Re: Turk et al and the "how do we spin wingspan?" commentary. AJNR Am J Neuroradiol. 2008 Sep; 29(8):e69; author reply e70.
    View in: PubMed
    Score: 0.012
  32. Treatment of intracranial atherosclerotic stenosis. Rev Neurol Dis. 2008; 5(3):117-24.
    View in: PubMed
    Score: 0.012
  33. Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial. Neuroimaging Clin N Am. 2007 Aug; 17(3):355-63, viii-ix.
    View in: PubMed
    Score: 0.012
  34. A clinical example of the "limping brain" syndrome: a case report. AJNR Am J Neuroradiol. 2005 Jun-Jul; 26(6):1521-4.
    View in: PubMed
    Score: 0.010
  35. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005 Mar 31; 352(13):1305-16.
    View in: PubMed
    Score: 0.010
  36. Antithrombotic therapy for atherosclerotic intracranial arterial stenosis. Adv Neurol. 2003; 92:271-4.
    View in: PubMed
    Score: 0.008
  37. Chronic remote ischaemic conditioning in patients with symptomatic intracranial atherosclerotic stenosis (the RICA trial): a multicentre, randomised, double-blind sham-controlled trial in China. Lancet Neurol. 2022 Dec; 21(12):1089-1098.
    View in: PubMed
    Score: 0.008
  38. Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory: Report of the AAN Guideline Subcommittee. Neurology. 2022 03 22; 98(12):486-498.
    View in: PubMed
    Score: 0.008
  39. Infarct Recurrence in Intracranial Atherosclerosis: Results from the MyRIAD Study. J Stroke Cerebrovasc Dis. 2021 Feb; 30(2):105504.
    View in: PubMed
    Score: 0.007
  40. Mitigating the effects of COVID-19 pandemic on controlling vascular risk factors among participants in a carotid stenosis trial. J Stroke Cerebrovasc Dis. 2020 Dec; 29(12):105362.
    View in: PubMed
    Score: 0.007
  41. Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial. Stroke. 2020 10; 51(10):2960-2971.
    View in: PubMed
    Score: 0.007
  42. Best treatment for intracranial arterial stenosis? 50 years of uncertainty. The WASID Investigators. Neurology. 2000 Aug 22; 55(4):465-6.
    View in: PubMed
    Score: 0.007
  43. Mechanisms of early Recurrence in Intracranial Atherosclerotic Disease (MyRIAD): Rationale and design. J Stroke Cerebrovasc Dis. 2020 Oct; 29(10):105051.
    View in: PubMed
    Score: 0.007
  44. National Institutes of Health StrokeNet During the Time of COVID-19 and Beyond. Stroke. 2020 08; 51(8):2580-2586.
    View in: PubMed
    Score: 0.007
  45. New ischemic lesions on brain magnetic resonance imaging in patients with blunt traumatic cerebrovascular injury. J Trauma Acute Care Surg. 2020 06; 88(6):796-802.
    View in: PubMed
    Score: 0.007
  46. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol. 2000 Apr; 21(4):643-6.
    View in: PubMed
    Score: 0.007
  47. Impact of Baseline Features and Risk Factor Control on Cognitive Function in the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial. Cerebrovasc Dis. 2019; 47(1-2):24-31.
    View in: PubMed
    Score: 0.006
  48. Type and Duration of Exercise in the SAMMPRIS Trial. Neurologist. 2019 Jan; 24(1):10-12.
    View in: PubMed
    Score: 0.006
  49. Treatment effect on ordinal functional outcome using piecewise multistate Markov model with unobservable baseline: an application to the modified Rankin scale. J Biopharm Stat. 2019; 29(1):82-97.
    View in: PubMed
    Score: 0.006
  50. Relationship between Risk Factor Control and Compliance with a Lifestyle Modification Program in the Stenting Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis Trial. J Stroke Cerebrovasc Dis. 2018 Mar; 27(3):801-805.
    View in: PubMed
    Score: 0.006
  51. Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia. J Neurosurg. 2018 09; 129(3):702-710.
    View in: PubMed
    Score: 0.006
  52. Effects of Spaceflight on Astronaut Brain Structure as Indicated on MRI. N Engl J Med. 2017 11 02; 377(18):1746-1753.
    View in: PubMed
    Score: 0.006
  53. Comparison of multistate Markov modeling with contemporary outcomes in a reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. PLoS One. 2017; 12(10):e0187050.
    View in: PubMed
    Score: 0.006
  54. Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials. Int J Stroke. 2017 10; 12(7):770-778.
    View in: PubMed
    Score: 0.006
  55. Frequency and severity of asymptomatic coronary disease in patients with different causes of stroke. Stroke. 1997 May; 28(5):941-5.
    View in: PubMed
    Score: 0.006
  56. Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis). Stroke. 2017 06; 48(6):1501-1506.
    View in: PubMed
    Score: 0.006
  57. Postprandial Clearance of Oxidized Low-Density Lipoprotein in Patients with Stroke Due to Atherosclerosis. J Stroke Cerebrovasc Dis. 2017 Mar; 26(3):488-493.
    View in: PubMed
    Score: 0.006
  58. Is There Benefit from Stenting on Cognitive Function in Intracranial Atherosclerosis? Cerebrovasc Dis. 2017; 43(1-2):31-35.
    View in: PubMed
    Score: 0.006
  59. Impact of the New American Heart Association/American Stroke Association Definition of Stroke on the Results of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial. J Stroke Cerebrovasc Dis. 2017 Jan; 26(1):108-115.
    View in: PubMed
    Score: 0.005
  60. The urgent need for contemporary clinical trials in patients with asymptomatic carotid stenosis. Neurology. 2016 Nov 22; 87(21):2271-2278.
    View in: PubMed
    Score: 0.005
  61. Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial. JAMA Neurol. 2016 Mar; 73(3):308-15.
    View in: PubMed
    Score: 0.005
  62. Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial. JAMA Neurol. 2016 Jan; 73(1):36-42.
    View in: PubMed
    Score: 0.005
  63. Characterization of intracranial atherosclerotic stenosis using high-resolution MRI study--rationale and design. Brain Behav. 2015 Dec; 5(12):e00397.
    View in: PubMed
    Score: 0.005
  64. Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis? Stroke. 2015 Nov; 46(11):3282-4.
    View in: PubMed
    Score: 0.005
  65. Do Patient Characteristics Explain the Differences in Outcome Between Medically Treated Patients in SAMMPRIS and WASID? Stroke. 2015 Sep; 46(9):2562-7.
    View in: PubMed
    Score: 0.005
  66. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology. 1995 Aug; 45(8):1488-93.
    View in: PubMed
    Score: 0.005
  67. Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysis. Stroke. 2015 Mar; 46(3):775-9.
    View in: PubMed
    Score: 0.005
  68. Ischemic stroke and TIA: clinical clues to common causes. Geriatrics. 1994 Jun; 49(6):37-42.
    View in: PubMed
    Score: 0.005
  69. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 Jul; 45(7):2160-236.
    View in: PubMed
    Score: 0.005
  70. Cardiac prognosis of patients with carotid stenosis and no history of coronary artery disease. Veterans Affairs Cooperative Study Group 167. Stroke. 1994 Apr; 25(4):759-65.
    View in: PubMed
    Score: 0.005
  71. Noninvasive fractional flow on MRA predicts stroke risk of intracranial stenosis. J Neuroimaging. 2015 Jan-Feb; 25(1):87-91.
    View in: PubMed
    Score: 0.005
  72. Death associated with asymptomatic carotid artery stenosis: long-term clinical evaluation. VA Cooperative Study 167 Group. J Vasc Surg. 1993 Dec; 18(6):1002-9; discussion 1009-11.
    View in: PubMed
    Score: 0.004
  73. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014 Jan 25; 383(9914):333-41.
    View in: PubMed
    Score: 0.004
  74. Left atrial spontaneous echo contrast is highly associated with previous stroke in patients with atrial fibrillation or mitral stenosis. Stroke. 1993 Jul; 24(7):1015-9.
    View in: PubMed
    Score: 0.004
  75. Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Neurosurgery. 2013 May; 72(5):777-95; discussion 795.
    View in: PubMed
    Score: 0.004
  76. Transcranial Doppler assessment of cerebral perfusion reserve in patients with carotid occlusive disease and no evidence of cerebral infarction. Neurology. 1993 Feb; 43(2):353-7.
    View in: PubMed
    Score: 0.004
  77. MUSC's comprehensive stroke program: changing what's possible in stroke care across South Carolina. J S C Med Assoc. 2012 Oct-Dec; 108(5):128-31.
    View in: PubMed
    Score: 0.004
  78. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke. 2012 Oct; 43(10):2682-8.
    View in: PubMed
    Score: 0.004
  79. Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial. J Neurointerv Surg. 2013 Nov; 5(6):528-33.
    View in: PubMed
    Score: 0.004
  80. Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial. Circ Cardiovasc Qual Outcomes. 2012 Sep 01; 5(5):e51-60.
    View in: PubMed
    Score: 0.004
  81. Utilization of CT perfusion patient selection for mechanical thrombectomy irrespective of time: a comparison of functional outcomes and complications. J Neurointerv Surg. 2013 Nov; 5(6):518-22.
    View in: PubMed
    Score: 0.004
  82. Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging. Arch Neurol. 1992 Jul; 49(7):747-52.
    View in: PubMed
    Score: 0.004
  83. Asymptomatic coronary artery disease in patients with stroke. Prevalence, prognosis, diagnosis, and treatment. Stroke. 1992 Mar; 23(3):433-6.
    View in: PubMed
    Score: 0.004
  84. Risk factors and outcome of patients with symptomatic intracranial stenosis presenting with lacunar stroke. Stroke. 2012 May; 43(5):1230-3.
    View in: PubMed
    Score: 0.004
  85. Transcranial Doppler ultrasound identifies patients with right-to-left cardiac or pulmonary shunts. Neurology. 1991 Dec; 41(12):1902-4.
    View in: PubMed
    Score: 0.004
  86. Etiology of motor or sensory stroke: a prospective study of the predictive value of clinical and radiological features. Ann Neurol. 1991 Oct; 30(4):519-25.
    View in: PubMed
    Score: 0.004
  87. CT perfusion-guided patient selection for endovascular treatment of acute ischemic stroke is safe and effective. J Neurointerv Surg. 2012 Jul; 4(4):261-5.
    View in: PubMed
    Score: 0.004
  88. Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol. 2011 Jun; 69(6):963-74.
    View in: PubMed
    Score: 0.004
  89. Treatment of intractable arterial hemorrhage during stereotactic brain biopsy with thrombin. Report of three patients. J Neurosurg. 1991 Feb; 74(2):301-3.
    View in: PubMed
    Score: 0.004
  90. Collateral circulation in symptomatic intracranial atherosclerosis. J Cereb Blood Flow Metab. 2011 May; 31(5):1293-301.
    View in: PubMed
    Score: 0.004
  91. Mechanism of stroke in patients taking aspirin. Neurology. 1990 Nov; 40(11):1682-5.
    View in: PubMed
    Score: 0.004
  92. Ipsilateral leg weakness associated with carotid stenosis. Stroke. 1990 Sep; 21(9):1362-4.
    View in: PubMed
    Score: 0.004
  93. Risk factors associated with severity and location of intracranial arterial stenosis. Stroke. 2010 Aug; 41(8):1636-40.
    View in: PubMed
    Score: 0.004
  94. Resolution of psychotic depression after right temporoparietal infarction. J Nerv Ment Dis. 1990 Jul; 178(7):458-9.
    View in: PubMed
    Score: 0.004
  95. The accuracy of bedside neurological diagnoses. Ann Neurol. 1990 Jul; 28(1):78-85.
    View in: PubMed
    Score: 0.004
  96. Intracranial hypertension associated with unruptured cerebral arteriovenous malformations. Ann Neurol. 1990 May; 27(5):474-9.
    View in: PubMed
    Score: 0.004
  97. HIV-associated CIDP. Muscle Nerve. 1989 Aug; 12(8):695-6.
    View in: PubMed
    Score: 0.003
  98. Periventricular lesions on MRI. Facts and theories. Stroke. 1989 Jul; 20(7):963-7.
    View in: PubMed
    Score: 0.003
  99. Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis. Stroke. 2009 Jun; 40(6):1999-2003.
    View in: PubMed
    Score: 0.003
  100. Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology. 2009 Jun 09; 72(23):2014-9.
    View in: PubMed
    Score: 0.003
  101. Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke. 2009 Feb; 40(2):505-9.
    View in: PubMed
    Score: 0.003
  102. Early stroke risk after transient ischemic attack among individuals with symptomatic intracranial artery stenosis. Arch Neurol. 2008 Jun; 65(6):733-7.
    View in: PubMed
    Score: 0.003
  103. Prevalence and prognosis of coexistent asymptomatic intracranial stenosis. Stroke. 2008 Mar; 39(3):1039-41.
    View in: PubMed
    Score: 0.003
  104. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology. 2008 Apr 22; 70(17):1518-24.
    View in: PubMed
    Score: 0.003
  105. Use of dose modification schedules is effective for blinding trials of warfarin: evidence from the WASID study. Clin Trials. 2008; 5(1):23-30.
    View in: PubMed
    Score: 0.003
  106. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology. 2007 Nov 27; 69(22):2063-8.
    View in: PubMed
    Score: 0.003
  107. Is there a role for heparin in the management of complications of subarachnoid hemorrhage? Stroke. 1987 Nov-Dec; 18(6):1169-72.
    View in: PubMed
    Score: 0.003
  108. Echocardiography in patients with symptomatic intracranial stenosis. J Stroke Cerebrovasc Dis. 2007 Sep-Oct; 16(5):216-9.
    View in: PubMed
    Score: 0.003
  109. Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis. Cerebrovasc Dis. 2007; 24(2-3):283-8.
    View in: PubMed
    Score: 0.003
  110. Gender differences in outcomes among patients with symptomatic intracranial arterial stenosis. Stroke. 2007 Jul; 38(7):2055-62.
    View in: PubMed
    Score: 0.003
  111. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation. 2007 Jun 12; 115(23):2969-75.
    View in: PubMed
    Score: 0.003
  112. The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology. 2007 Jun 12; 68(24):2099-106.
    View in: PubMed
    Score: 0.003
  113. Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology. 2006 Oct 10; 67(7):1275-8.
    View in: PubMed
    Score: 0.003
  114. Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis. Neurology. 2006 May 09; 66(9):1344-9.
    View in: PubMed
    Score: 0.003
  115. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006 Jan 31; 113(4):555-63.
    View in: PubMed
    Score: 0.003
  116. A computerized genetic record system. S Afr Med J. 1984 Feb 11; 65(6):206-9.
    View in: PubMed
    Score: 0.002
  117. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Circulation. 2003 Sep 09; 108(10):1278-90.
    View in: PubMed
    Score: 0.002
  118. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Stroke. 2003 Sep; 34(9):2310-22.
    View in: PubMed
    Score: 0.002
  119. Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women. Stroke. 2002 Dec; 33(12):2762-8.
    View in: PubMed
    Score: 0.002
  120. Right atrial spontaneous contrast: echocardiographic and clinical features. Int J Card Imaging. 1994 Sep; 10(3):227-32.
    View in: PubMed
    Score: 0.001
  121. Neurologic complications related to cardiac surgery. Neurol Clin. 1992 Feb; 10(1):145-66.
    View in: PubMed
    Score: 0.001
  122. Comparison of transcranial Doppler ultrasound and transesophageal contrast echocardiography in the detection of interatrial right-to-left shunts. Am J Cardiol. 1991 Dec 01; 68(15):1498-502.
    View in: PubMed
    Score: 0.001
  123. Sclerosing vasculopathy of the central nervous system in nonelderly demented patients. Arch Neurol. 1991 Jun; 48(6):631-6.
    View in: PubMed
    Score: 0.001
  124. Detection and evaluation of intrapulmonary vascular shunt with "contrast Doppler" transesophageal echocardiography. J Am Soc Echocardiogr. 1991 Jan-Feb; 4(1):79-83.
    View in: PubMed
    Score: 0.001
  125. Stroke in patients with fusiform vertebrobasilar aneurysms. Neurology. 1989 Jan; 39(1):16-21.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.